2Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti MT. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 1993;7:295-299
3Krammer LM. The role of octreotide in malignant bowel obstruction. Oncol Nurs Forum 1999;26:831-832
4Ripamonti C, Panzeri C, Groff L, Galeazzi G, Boffi R. The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results. Tumori 2001;87:1-9
5Mystakidou K, Tsilika E, Kalaidopoulou O, Chondros K,Georgaki S, Papadimitriou L. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial.Anticancer Res 2002;22:1187-1192
6Wright HK, O′Brien JJ, Tilson MD. Water absorption in experimental closed segment obstruction of the ileum in man.Am J Surg 1971;121:96-99
7Dharmsathaphor K, Binder HJ, Dobbins JW. Somatostatin stimulates sodium and chloride absorption in the rabbit ileum.Gastroenterology 1980;78:1559-1565
8Nellgard P, Bojo L, Cassuto J. Importance of vasoactive intestinal peptide and somatostatin for fluid losses in small-bowel obstruction. Scand J Gastroenterol 1995;30:464-469
9Yamaner S, Bugra D, Muslumanoglu M, Bulut T, Cubukcu O, Ademoglu E. Effects of octreotide on healing of intestinal anastomosis following small bowel obstruction in rats. Dis Colon Rectum 1995;38:308-312
10Mangili G, Franchi M, Mariani A, Zanaboni F, Rabaiotti E,Frigerio L, Bolis PF, Ferrari A. Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol 1996;61:345-348
5Tahrani AA, Bailey C J, De1 Prato S, et al. Management of type 2 diabetes: new and future developments in treatment [ J ]. Lancet, 2011,378 (9786) :182-197.
6Mitka M. Bariatfic surgery continues to show benefits for patientswith diabetes[ Jl. JAMA,2012,307(18) :1901-1902.
7Basevi V, Di Marie S, Moreiano C, et al. Comment on : American Diabetes Association. Standards of medical care in diabetes-- 2011. Diabetes Care 2011 ;34( Suppl. 1 ) :Sll-$61 [ J]. Diabetes Care,2011,34 ( 5 ) : e53 ; author reply e54.
8Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes[ J]. N En- gl J Med,2012,366(17) :1577-1585.
